3 Drugs That Could Make-or-Break AbbVie Post author:Sam Post published:February 11, 2018 Post category:BioPharma A look at three drug approvals of vital importance to the company this year. Source: BioSpace You Might Also Like Summit Therapeutics Reports Financial Results For The Second Quarter And Half Year Ended 31 July 2017 And Operational Progress August 30, 2017 Gilead's Kite Pays $135M for Ex-Agensys R&D Building January 22, 2018 Massive FDA and NIH Cuts in Outlined Budget Plan May 22, 2017
Summit Therapeutics Reports Financial Results For The Second Quarter And Half Year Ended 31 July 2017 And Operational Progress August 30, 2017
